Skip to main content

Closed

TELA: TELA Bio, Inc. Stock Analysis | finqOS

Healthcare · Medical - Devices

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+15.8% / yr

Operating margin-41.8%

ROIC-64.3%

Financially safe

Stretched

Debt / equity-10.84×

Interest coverage-17.1×

Current ratio3.61×

TELA Bio, Inc.

TELANASDAQ·USD·Closed

TELA Bio, Inc.

TELANASDAQ·USD·Closed

$0.73

+2.83%

$0.73

+$0.02 (2.83%)

52W Range

14thpctl

Volume

0.15×avg

Mkt Cap

32.67MUSD

P/E

-0.9TTM

Div Yield

–ann

52W Range

14thpctl

Volume

0.15×avg

Market Cap

32.67MUSD

P/E Ratio

-0.9TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings